K Herrlinger

Statistics

Publications

Citations

996

H-Index

Active since

2003

Affiliations

Robert Bosch Hospital(Current)

University of Lübeck

University Hospital Schleswig-Holstein

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Asklepios Kliniken Hamburg

K Herrlinger is an author at Robert Bosch Hospital specializing in inflammatory bowel disease, gastrointestinal inflammation, and gastrointestinal pharmacotherapy.

Publications per year

2003–2015

Publications

NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression

Jan Wehkamp, Jürgen Harder, Michael Weichenthal et al. · Gut · 2004 · 796 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

K. J. Schmidt, K Herrlinger, Jörg Emmrich et al. · Alimentary Pharmacology & Therapeutics · 2012 · 84 citations

Pharmacy, Pharmacotherapy, Surgery +13

Remission maintenance by tioguanine in chronic active Crohn's disease

K Herrlinger, Peter Deibert, Matthias Schwab et al. · Alimentary Pharmacology & Therapeutics · 2003 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

K Herrlinger, Hülya Koç, Stefan Winter et al. · Clinical Pharmacology & Therapeutics · 2011 · 46 citations

Medicine, Genetics, Molecular Genetics +17

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

K. J. Schmidt, Niklas F. Müller, Daniel C. Baumgart et al. · Journal of Crohn s and Colitis · 2015 · 23 citations · Full text

Medicine, Surgery, Gastrointestinal Pharmacotherapy +11

1–5 of 5